1069EGP
- Active ingredient
- rivastigmine
- Strength
- 18 mg + 9.5mg
- Form
- piece
- Manufacturer
- lts lohmann therapie systeme ag-germany > novartis
- Route
- unknown
Uses
Used for mild, moderate, and severe Alzheimer's disease dementia and mild-to-moderate dementia associated with Parkinson's disease.
Do not use if
Contraindicated in patients with hypersensitivity to rivastigmine, carbamate derivatives, or formulation components.
Side effects
Nausea, vomiting, diarrhea, loss of appetite, dizziness, and skin reactions may occur.
Warnings
May cause significant gastrointestinal adverse effects. Ensure proper use of transdermal patches to avoid overdose.
How it works
Reversible cholinesterase inhibitor that increases acetylcholine concentrations in the brain.
Storage
Store according to product instructions at room temperature.
